METHYL PREDNISILONE ACETATE

CAS Number: 53-36-1

Molecular Formula: C24H32O6

About METHYL PREDNISILONE ACETATE

Methylprednisolone acetate (CAS 53-36-1) serves as a critical 99% purity pharmaceutical-grade glucocorticoid receptor agonist within the US b2b market, specialized for long-acting injectable suspensions to manage severe inflammatory and autoimmune conditions like rheumatoid arthritis and acute asthma. 6alpha-Methylpred...

METHYL PREDNISILONE ACETATE Specifications

CAS Number

53-36-1

Molecular Formula

C24H32O6

Molecular Weight

416.51 g/mol

IUPAC Name

[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate

Canonical SMILES

CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O

InChI Key

PLBHSZGDDKCEHR-LFYFAGGJSA-N

PubChem CID

5877.0

CAS Number

53-36-1

Molecular Formula

C24H32O6

Molecular Weight

416.51 g/mol

IUPAC Name

[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate

Canonical SMILES

CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O

InChI Key

PLBHSZGDDKCEHR-LFYFAGGJSA-N

PubChem CID

5877.0

Molecular Weight

416.51 g/mol

Physical appearance

White to light yellow powder to crystal

Pharmaceutical Research Reagent

A synthetic glucocorticoid receptor agonist used in life science research to study immunosuppressive and anti-inflammatory effects on cell signaling, gene expression, and cytokine production

Anti-inflammatory Agent

A potent corticosteroid employed in clinical and experimental settings to manage a wide range of inflammatory conditions, including arthritis, asthma, and dermatological disorders

Immunosuppressant

A pharmaceutical building block utilized to modulate immune responses in autoimmune diseases and transplant rejection studies

Reference Standard

A high-purity chemical used as a certified reference material for analytical testing, system suitability, and quality control in pharmaceutical development.